Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
14.57
-0.53 (-3.51%)
At close: Aug 25, 2025, 4:00 PM
14.57
0.00 (0.00%)
After-hours: Aug 25, 2025, 4:37 PM EDT
Zymeworks Market Cap
Zymeworks has a market cap or net worth of $1.10 billion as of August 25, 2025. Its market cap has increased by 56.81% in one year.
Market Cap
1.10B
Enterprise Value
781.23M
1-Year Change
56.81%
Ranking
Category
Stock Price
$14.57
Market Cap Chart
Since April 28, 2017, Zymeworks's market cap has increased from $329.40M to $1.10B, an increase of 232.47%. That is a compound annual growth rate of 15.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 1.14B | 12.55% |
| Dec 31, 2024 | 1.01B | 38.65% |
| Dec 29, 2023 | 727.30M | 46.87% |
| Dec 30, 2022 | 495.20M | -35.10% |
| Dec 31, 2021 | 763.00M | -64.77% |
| Dec 31, 2020 | 2.17B | 20.97% |
| Dec 31, 2019 | 1.79B | 281.53% |
| Dec 31, 2018 | 469.30M | 143.92% |
| Dec 29, 2017 | 192.40M | -41.59% |
| Apr 28, 2017 | 329.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 638.90B |
| Johnson & Johnson | 431.79B |
| AbbVie | 372.04B |
| UnitedHealth Group | 278.42B |
| Novo Nordisk | 253.97B |
| AstraZeneca | 251.25B |
| Novartis AG | 246.51B |
| Abbott Laboratories | 230.77B |